BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4208341)

  • 1. Clinical evaluation of SE 1520 in the treatment of hypertension.
    Seedat YK; Reddy J
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):275-80. PubMed ID: 4208341
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: SE 1520 in the treatment of hypertension.
    Seedat YK; Reddy J
    S Afr Med J; 1974 Feb; 48(8):286. PubMed ID: 4814507
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of metolazone in the long-term treatment of essential hypertension.
    Cangiano JL; Campos JA; Trevino A; Ramirez-Gonzalez R; Ramirez-Muzo O
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):778-85. PubMed ID: 4217244
    [No Abstract]   [Full Text] [Related]  

  • 4. Why less severe degrees of hypertension should be treated.
    Moser M; Gifford RW
    J Hypertens; 1985 Oct; 3(5):437-47. PubMed ID: 3905960
    [No Abstract]   [Full Text] [Related]  

  • 5. Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.
    Collins IS; King IW
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):185-94. PubMed ID: 4402011
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial of a new diuretic--metindamide.
    Burger P; Anderson IF
    S Afr Med J; 1974 Mar; 48(13):546-9. PubMed ID: 4596015
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive effects of metolazone (zaroxolyn).
    Materson BJ; Oster JR; Perez-Stable EC
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):890-6. PubMed ID: 4214663
    [No Abstract]   [Full Text] [Related]  

  • 8. [American hypertension guidelines discussed. Are diuretics really the best first-line therapy?].
    MMW Fortschr Med; 2003 Aug; 145(31-32):50. PubMed ID: 14524075
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive efficacy of metolazone.
    Fotiu S; Mroczek WJ; Davidov M; Finnerty FA
    Clin Pharmacol Ther; 1974 Aug; 16(2):318-21. PubMed ID: 4850607
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
    Kramer R; Rosendorff C; Bloom D
    S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary clinical trial of Prazosin: a new oral antihypertensive agent.
    Bolli P; Simpson FO
    N Z Med J; 1974 May; 79(516):969-72. PubMed ID: 4152750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proven in the practice. Follow up of the use confirms high trial value].
    MMW Fortschr Med; 2003 Dec; 145(51-52):37. PubMed ID: 14974328
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical changes during moduretic treatment of hypertension in African patients.
    Ahaneku JE; Taylor GO; Walker O; Agbedana EO; Salako LA
    Kobe J Med Sci; 1995 Aug; 41(4):83-93. PubMed ID: 8904160
    [No Abstract]   [Full Text] [Related]  

  • 15. How to treat arterial hypertension.
    Finnerty FA
    Am Fam Physician; 1973 Apr; 7(4):99-108. PubMed ID: 4694341
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of patients with hypertension resistant to treatment].
    Girerd X; Hanon O
    Rev Prat; 1999 Mar; 49(5):527-31. PubMed ID: 10358403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt substitute as potassium replacement in hypertensive patients.
    Perry RS
    Clin Pharm; 1986 Feb; 5(2):156-9. PubMed ID: 3956125
    [No Abstract]   [Full Text] [Related]  

  • 18. Step 1 1/2 therapy for the treatment of hypertension.
    Miller SA; Cobb SD; Petrulis AS; Vertes V
    Ohio State Med J; 1985 Jan; 81(1):57, 59-61, 63. PubMed ID: 3881712
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug therapy. 3. Treatment of uncomplicated hypertension.
    Aagaard GN
    Northwest Med; 1970 Feb; 69(2):99-101. PubMed ID: 5414644
    [No Abstract]   [Full Text] [Related]  

  • 20. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.